机构：[1]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China神经内科首都医科大学宣武医院[2]Department of Medicine, Sichuan Scientific and Cellular Biotechnology Research Institute, Chengdu, 610041, China
Context: There is a need to improve stroke care through the prompt identification of stroke patients at increased risk of an adverse outcome. Objective: To evaluate the prognostic value of copeptin in patients with stroke. Methods: We systematically searched PubMed and Embase for relevant studies. Poor outcome and mortality were analyzed. Results: Twelve studies, containing 2682 patients, were included. Pooled analysis showed that copeptin is an independent prognostic marker of poor outcome after acute stroke and there is a borderline effect of copeptin in predicting mortality after acute stroke. Conclusions: Copeptin is an independent predictor of poor outcome and mortality for patients with acute stroke.
第一作者机构：[1]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
推荐引用方式(GB/T 7714)：
Lidong Jiao,Changbiao Chu,Shijie Zhou.Prognostic value of copeptin in patients with acute stroke[J].EXPERT REVIEW OF NEUROTHERAPEUTICS.2015,15(5):563-570.doi:10.1586/14737175.2015.1030734.
APA：
Lidong Jiao,Changbiao Chu&Shijie Zhou.(2015).Prognostic value of copeptin in patients with acute stroke.EXPERT REVIEW OF NEUROTHERAPEUTICS,15,(5)
MLA：
Lidong Jiao,et al."Prognostic value of copeptin in patients with acute stroke".EXPERT REVIEW OF NEUROTHERAPEUTICS 15..5(2015):563-570
：